Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > Top Cannabis MSOs will Grow & Weather the Economic Storm
View:
Post by blackspade799 on Apr 04, 2023 5:35pm

Top Cannabis MSOs will Grow & Weather the Economic Storm

Cannabis is the only industry in todays economic inflation period where its products continues to drop in value due to the black market, while its industry continues to grow in value and CURA has positioned it self in the right States to continue it growth. While the U.S. Federal government over taxes legal MSOs(280E), and blocks them from writing off its expensses and from borrowing money and using credit and debt cards. State goverments like Cali and NY continue to play possum and ignore illegal cannabis stores in their States. CURA will weather the storm, with CSE uplisting this May with cheaper charges on the new Senior Tier platform and a potential move to get margin trading approved will be a massive! catayst for the sp. UK and Germany's Medical Cannabis continues to grow for CURA Inter. CURAs new products continue to be rolled out, and the NY, NJ CI wholesale market is picking up while new medical and adutl use states open (Kentucky/Maryland..) A potential uplisting on the CSE will bring in major institutional investors which would catapult the stock-price for CURA even with out margin trading. Mid/Small cannabis players will continue to see capituilation. CURA will see a major drop in cappex by 40-50% in Q1 - they have all they need now built in, in order to build out. CURA has done $626 Million in 2020 $1.2 Billion in 2021 and $1.4Billion in 2022 and still growing YoY and cash on hand. With major saving in Capex and continued growth in NJ,CI, FL,NY...United Kingdom and Germany CURA is by far the best in its class that can see a 5x 10x spike with a new Senior Tier Uplisting this May. This summer we could see the Department of Health and Human Services and the Attorny General remove cannabis from Schedule 1 to a Schedule 3. We are in a fantastic financial position with many many catalysts. At current sp Curaleaf is Prime for major sp growth very soon. Good Luck longs...not for long ;)
Comment by blackspade799 on Apr 04, 2023 5:57pm
Cannabis is in the same federal category as heroin “with no medical value” and 38 states have a medical marijuana program. What exactly else do you need @SecBecerra ? When they say it takes 20 government employees to screw in a lightbulb, cannabis is a prime example. https://twitter.com/stock_mj/status/1643358190644387841?s=20
Comment by Bullknit101 on Apr 04, 2023 10:45pm
Very well said backspace. I wish I could share your enthusiasm and optimism. I feel the CSE Top Tier may be marginally better for Cura and re-scheduling timeline will be beyond this summer. The HHS clearly indicated that the DEA had the final say and I think that's where the risk lies. The DEA has bias against Cannabis.  Once we get the latest Q results, we'll know what we're ...more  
Comment by blackspade799 on Apr 05, 2023 5:48am
Let go with your sentiment, let’s say zero chance they Reschedule cannabis and let’s say nothing comes about with CSE Senior Tier uplisting. Let’s say we enter a massive recession alcohol and cigarettes were comfort vices in the past, we have graduated from those toxic remedies and are now moving into CBD, THC Therapeutics with massive benefits not just with cognitive but also a socially accepted ...more  
Comment by ledzep4u on Apr 05, 2023 10:17am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities